Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Korea.
Department of Anesthesiology and Pain Medicine, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Korea.
Surg Endosc. 2022 Jul;36(7):5491-5500. doi: 10.1007/s00464-021-08910-3. Epub 2022 Jan 10.
Pheochromocytoma often carries a risk for perioperative hemodynamic instability (HDI). The aim of this study is to evaluate the risk factors of intraoperative HDI during minimally invasive posterior retroperitoneal adrenalectomy (PRA) for pheochromocytoma.
This retrospective study analyzed the prospectively collected data of 172 patients who underwent laparoscopic PRA or robotic PRA for pheochromocytoma between January 2014 and December 2020 at a single tertiary center. The patients were divided into two groups according to the intraoperative hypertensive event of systolic blood pressure (> 160 mmHg). The clinical manifestations and perioperative hemodynamic conditions were analysed.
In the multivariate logistic regression analysis, the tumor size (> 3.4 cm) [OR 3.14, 95% confidence intervals (CI) (1.48-6.64), p = 0.003], type of preoperative alpha-blocker (selective type) [OR 3.9, 95% CI (1.52-10.02), p = 0.005], preoperative use of beta-blockers [OR 3.94, 95% CI (1.07-14.49), p = 0.039] and type of anesthesia [total intravenous anesthesia (TIVA) vs. balanced anesthesia (BA)] [OR 2.57, 95% CI (1.23-5.38), p = 0.012] were determined as independent risk factors of intraoperative hypertensive events during minimally invasive adrenalectomy.
The type of anesthesia was independently associated with intraoperative HDI along with larger tumor size, type of preoperative alpha-blocker and the use of preoperative beta-blockers. TIVA increased the risk of intraoperative hypertensive events compared with BA. Thus, the consideration of the type of anesthesia prior to adrenal surgery for pheochromocytoma along with the use of preoperative non-selective alpha-blockers may be beneficial in minimizing the risk of intraoperative HDI.
嗜铬细胞瘤常伴有围手术期血流动力学不稳定(HDI)的风险。本研究旨在评估微创后腹腔镜肾上腺切除术(PRA)治疗嗜铬细胞瘤术中发生 HDI 的危险因素。
本回顾性研究分析了 2014 年 1 月至 2020 年 12 月期间在一家三级医院接受腹腔镜或机器人 PRA 治疗嗜铬细胞瘤的 172 例患者的前瞻性收集数据。根据术中收缩压(>160mmHg)的高血压事件,将患者分为两组。分析了临床表现和围手术期血流动力学情况。
在多变量逻辑回归分析中,肿瘤大小(>3.4cm)[OR 3.14,95%置信区间(CI)(1.48-6.64),p=0.003]、术前 α 受体阻滞剂类型(选择性)[OR 3.9,95%CI(1.52-10.02),p=0.005]、术前使用β受体阻滞剂[OR 3.94,95%CI(1.07-14.49),p=0.039]和麻醉类型[全凭静脉麻醉(TIVA)与平衡麻醉(BA)] [OR 2.57,95%CI(1.23-5.38),p=0.012]是微创肾上腺切除术中发生术中高血压事件的独立危险因素。
麻醉类型与较大肿瘤大小、术前 α 受体阻滞剂类型和术前使用β受体阻滞剂一起与术中 HDI 独立相关。与 BA 相比,TIVA 增加了术中高血压事件的风险。因此,在进行嗜铬细胞瘤肾上腺手术前考虑麻醉类型并使用非选择性术前 α 受体阻滞剂可能有助于降低术中 HDI 的风险。